The initial action of MOTS-c treatment could increase antioxidant responses by increasing protein expressions of superoxide dismutase, catalase, and glutathione peroxidase 4, as reported in a previous study on T1D hearts (Tang et al., 2023). This evidence concerns the gene CAT and type 1 diabetes mellitus.